This is a machine translation provided by the European Commission’s eTranslation service to help you understand this page. Please read the conditions of use.
A systems biology approach to RESOLVE the molecular pathology of two hallmarks of patients with metabolic syndrome and its co-morbidities; hypertriglyceridemia and low HDL-cholesterol